Trials / Recruiting
RecruitingNCT05147519
Protocol RV 583 Multinational Observational Cohort of HIV and Other Infections
Multinational Observational Cohort of HIV and Other Infections (MOCHI)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,500 (estimated)
- Sponsor
- Henry M. Jackson Foundation for the Advancement of Military Medicine · Academic / Other
- Sex
- All
- Age
- 14 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
Multinational Observational Cohort of HIV and other Infections (MOCHI). This observational study is to gain information regarding the number of new HIV infections among people who engage in behaviors that make them vulnerable to acquiring HIV across multiple international sites.
Detailed description
Prospective observational cohort study of participants vulnerable to HIV, conducted in three Steps. Step 1 will enroll participants aged 14-55 years who are vulnerable to contracting HIV. They will be evaluated every 12 weeks for HIV and other sexually transmitted infections (STIs). Participants who are diagnosed with HIV will proceed to Step 2, with evaluation of viral load and other HIV-related tests every four weeks for 12 weeks and then every 12 weeks for a total of 48 weeks. Participants who achieve and maintain viral suppression in Step 2 will proceed to Step 3 for continued HIV monitoring every 24 weeks to document maintenance of viral suppression and maintain engagement with the study site for potential future recruitment into interventional studies, including clinical trials of novel strategies to achieve HIV remission.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Novel interventions to achieve HIV remission | To establish a group of well-characterized people living with HIV who initiated ART during acute or early HIV transmission that can serve as a source population for future studies, including those designed to test novel interventions to achieve HIV remission. |
Timeline
- Start date
- 2021-11-05
- Primary completion
- 2027-06-30
- Completion
- 2032-06-30
- First posted
- 2021-12-07
- Last updated
- 2025-03-06
Locations
3 sites across 3 countries: Kenya, Philippines, Uganda
Source: ClinicalTrials.gov record NCT05147519. Inclusion in this directory is not an endorsement.